BrightPath Biotherapeutics Co.,Ltd. Stock Forecast
BrightPath Biotherapeutics Co.,Ltd. stock downgraded from Buy Candidate to Sell Candidate after Wednesday trading session.
(Updated on May 22, 2024)
The BrightPath Biotherapeutics Co.,Ltd. stock price fell by -1.67% on the last day (Wednesday, 22nd May 2024) from JP¥60.00 to JP¥59.00. During the last trading day the stock fluctuated 3.39% from a day low at JP¥59.00 to a day high of JP¥61.00. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume has increased on the last day by 42 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 208 thousand shares were bought and sold for approximately JP¥12.26 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.90% during the next 3 months and, with a 90% probability hold a price between JP¥35.89 and JP¥46.55 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
4594.T Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 5.36%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The BrightPath Biotherapeutics Co.,Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at JP¥59.00 and JP¥59.66. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for BrightPath Biotherapeutics Co.,Ltd. stock
BrightPath Biotherapeutics Co.,Ltd. finds support from accumulated volume at JP¥58.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved JP¥2.00 (3.39%) between high and low. For the last week, the stock has had daily average volatility of 3.06%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (4594.T) For The Upcoming Trading Day Of Thursday 23rd
For the upcoming trading day on Thursday, 23rd we expect BrightPath Biotherapeutics Co.,Ltd. to open at JP¥59.67, and during the day (based on 14 day Average True Range), to move between JP¥56.48 and JP¥61.52, which gives a possible trading interval of +/-JP¥2.52 (+/-4.28%) up or down from last closing price. If BrightPath Biotherapeutics Co.,Ltd. takes out the full calculated possible swing range there will be an estimated 8.55% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at JP¥58.00 (1.69%) than the resistance at JP¥62.00 (5.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is BrightPath Biotherapeutics Co.,Ltd. stock A Buy?
BrightPath Biotherapeutics Co.,Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -2.435 Sell Candidate Downgraded
Predicted Opening Price for BrightPath Biotherapeutics Co.,Ltd. of Thursday, May 23, 2024
| Fair opening price May 23, 2024 | Current price |
|---|---|
| JP¥59.67 ( 1.13%) | JP¥59.00 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for 4594.T
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 61.67 | 4.52 % | |
| R2 | 60.90 | 3.22 % | ||
| R1 | 60.43 | 2.42 % | ||
| Current price: | 59.00 | |||
| Support | S1 | 58.90 | -0.165 % | |
| S2 | 58.43 | -0.96 % | ||
| S3 | 57.67 | -2.26 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 72.00 | 22.03 % | |
| R2 | 66.00 | 11.86 % | ||
| R1 | 62.00 | 5.08 % | ||
| Current price | 59.00 | |||
| Support | S1 | 58.00 | -1.69% | |
| S2 | 57.00 | -3.39% | ||
| S3 | 56.00 | -5.08% |
FAQ
Click here for our free guide on how to buy BrightPath Biotherapeutics Co.,Ltd. Stock.
